FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W202466980> ?p ?o ?g. }

• W202466980 endingPage "162" @default.
• W202466980 startingPage "156" @default.
• W202466980 abstract "This randomized, single-blind, parallel group study was conducted to compare omeprazole with ranitidine for the treatment of symptoms associated with gastroesophageal reflux disease (GERD), uncomplicated duodenal ulcer (DU) or both. After baseline assessments, patients were randomized to receive daily treatment with either 20 mg omeprazole or 300 mg ranitidine for four weeks. In total, 1481 patients (1001 omeprazole, 480 ranitidine) with a diagnosis of GERD (n=904) and/or DU (n=577), confirmed by endoscopy or barium meal and reporting moderate to severe symptoms, were included in the analyses. The seventy of overall daytime symptoms reported by the omeprazole group at clinic visits was lower than that reported by the ranitidine group at week 2 for the entire patient group (P=0.0002) and at both weeks 2 and 4 for the subgroup of patients with GERD (P=0.0001 and P=0.001, respectively). The severity of overall night-time symptoms reported by the omeprazole group was lower than that reported by the ranitidine group at week 4 for all patients as a whole (P=0.042) and at both weeks 2 and 4 for the subgroup of patients with GERD (P=0.035 and P=0.010, respectively). There were no significant differences in reports of adverse events. In the omeprazole group, 19% of patients at week 2 and 15% of patients at week 4 reported adverse events, while the corresponding results from the ranitidine group were 21% and 11%. In conclusion, patients with GERD, DU or both treated with omeprazole 20 mg daily for four weeks showed statistically significant reductions in symptoms compared with patients treated with ranitidine 300 mg daily for the same period of time. The percentage of patients with any remaining daytime symptoms was 12% lower in the omeprazole group compared with the ranitidine group at week 2, and 7% lower at week 4. Five per cent fewer patients in the omeprazole group experienced night-time symptoms at either week 2 or week 4." @default.
• W202466980 created "2016-06-24" @default.
• W202466980 creator A5001076968 @default.
• W202466980 creator A5018579767 @default.
• W202466980 creator A5059184078 @default.
• W202466980 creator A5061755302 @default.
• W202466980 creator A5065725030 @default.
• W202466980 creator A5085121338 @default.
• W202466980 creator A5085660117 @default.
• W202466980 creator A5089365788 @default.
• W202466980 date "1996-01-01" @default.
• W202466980 modified "2023-09-27" @default.
• W202466980 title "Comparison of Omeprazole with Ranitidine for Treatment of Symptoms Associated with Gastroesophageal Reflux Disease and Uncomplicated Duodenal Ulcer" @default.
• W202466980 cites W1985499927 @default.
• W202466980 cites W1989111548 @default.
• W202466980 cites W2032038267 @default.
• W202466980 cites W2038496924 @default.
• W202466980 cites W2416550496 @default.
• W202466980 doi "https://doi.org/10.1155/1996/496721" @default.
• W202466980 hasPublicationYear "1996" @default.
• W202466980 type Work @default.
• W202466980 sameAs 202466980 @default.
• W202466980 citedByCount "2" @default.
• W202466980 countsByYear W2024669802013 @default.
• W202466980 crossrefType "journal-article" @default.
• W202466980 hasAuthorship W202466980A5001076968 @default.
• W202466980 hasAuthorship W202466980A5018579767 @default.
• W202466980 hasAuthorship W202466980A5059184078 @default.
• W202466980 hasAuthorship W202466980A5061755302 @default.
• W202466980 hasAuthorship W202466980A5065725030 @default.
• W202466980 hasAuthorship W202466980A5085121338 @default.
• W202466980 hasAuthorship W202466980A5085660117 @default.
• W202466980 hasAuthorship W202466980A5089365788 @default.
• W202466980 hasBestOaLocation W2024669801 @default.
• W202466980 hasConcept C126322002 @default.
• W202466980 hasConcept C168563851 @default.
• W202466980 hasConcept C197934379 @default.
• W202466980 hasConcept C2777014526 @default.
• W202466980 hasConcept C2777445857 @default.
• W202466980 hasConcept C2777498785 @default.
• W202466980 hasConcept C2779134260 @default.
• W202466980 hasConcept C43270747 @default.
• W202466980 hasConcept C71924100 @default.
• W202466980 hasConcept C90924648 @default.
• W202466980 hasConceptScore W202466980C126322002 @default.
• W202466980 hasConceptScore W202466980C168563851 @default.
• W202466980 hasConceptScore W202466980C197934379 @default.
• W202466980 hasConceptScore W202466980C2777014526 @default.
• W202466980 hasConceptScore W202466980C2777445857 @default.
• W202466980 hasConceptScore W202466980C2777498785 @default.
• W202466980 hasConceptScore W202466980C2779134260 @default.
• W202466980 hasConceptScore W202466980C43270747 @default.
• W202466980 hasConceptScore W202466980C71924100 @default.
• W202466980 hasConceptScore W202466980C90924648 @default.
• W202466980 hasIssue "3" @default.
• W202466980 hasLocation W2024669801 @default.
• W202466980 hasLocation W2024669802 @default.
• W202466980 hasOpenAccess W202466980 @default.
• W202466980 hasPrimaryLocation W2024669801 @default.
• W202466980 hasRelatedWork W202466980 @default.
• W202466980 hasRelatedWork W2067205465 @default.
• W202466980 hasRelatedWork W2072910086 @default.
• W202466980 hasRelatedWork W2087179433 @default.
• W202466980 hasRelatedWork W2373917225 @default.
• W202466980 hasRelatedWork W2381138204 @default.
• W202466980 hasRelatedWork W2381168924 @default.
• W202466980 hasRelatedWork W2439917345 @default.
• W202466980 hasRelatedWork W3032748646 @default.
• W202466980 hasRelatedWork W2470922972 @default.
• W202466980 hasVolume "10" @default.
• W202466980 isParatext "false" @default.
• W202466980 isRetracted "false" @default.
• W202466980 magId "202466980" @default.
• W202466980 workType "article" @default.